NCT02071862 · Interventional trial
Study of the Glutaminase Inhibitor CB-839 in Solid Tumors
Overall registry status Completed
Phase 1
Conditions Fumarate Hydratase (FH)-Deficient Tumors, Mesothelioma, Non Small Cell Lung Cancer, Renal Cell Carcinoma, Solid Tumors, Succinate Dehydrogenase (SDH)-Deficient Gastrointestinal Stromal Tumors (GIST), Succinate Dehydrogenase (SDH)-Deficient Non-gastrointestinal Stromal Tumors, Triple-Negative Breast Cancer, Tumors Harboring Amplifications in the cMyc Gene, Tumors Harboring Isocitrate Dehydrogenase-1 (IDH1) and IDH2 Mutations
Delaware Valley sites
- University of Pennsylvania, Abramson Cancer Center · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory